只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-28 2026-07-30 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V Director | 卖出（S） | 1,250 | US$182.01 | US$227,507.50 | 1,588 | SEC |
| 2026-07-16 2026-07-20 | LNBIX Lincoln Bain Capital Total Credit Fund | Lincoln Financial Investments Corp TenPercentOwner,Other | 买入（P） | 2,460,629.92 | US$10.16 | US$2500万 | 25,154,976.98 | SEC |
| 2026-07-10 2026-07-13 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 4,367 | US$181.02 | US$790,514.34 | 16,225 | SEC |
| 2026-07-09 2026-07-13 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 10,000 | US$179.60 | US$179.6万 | 54,729 | SEC |
| 2026-07-09 2026-07-09 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 8,433 | US$178.72 | US$150.71万 | 16,225 | SEC |
| 2026-07-08 2026-07-09 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 2,737 | US$178.54 | US$488,672.19 | 16,225 | SEC |
| 2026-07-07 2026-07-09 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 3,401 | US$178.57 | US$607,305.01 | 16,225 | SEC |
| 2026-06-29 2026-06-30 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 1,690 | US$170.81 | US$288,668.90 | 54,729 | SEC |
| 2026-06-29 2026-06-30 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 8,110 | US$170.03 | US$137.89万 | 54,729 | SEC |
| 2026-06-26 2026-06-30 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 200 | US$169.57 | US$33,914.00 | 54,729 | SEC |
| 2026-06-17 2026-06-22 | LNBIX Lincoln Bain Capital Total Credit Fund | Lincoln Financial Investments Corp TenPercentOwner,Other | 买入（P） | 2,453,385.67 | US$10.19 | US$2500万 | 22,544,866.82 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 7,883 | US$163.81 | US$129.13万 | 32,977 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 2,549 | US$164.44 | US$419,157.56 | 30,428 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 6,896 | US$165.79 | US$114.33万 | 23,532 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 5,829 | US$166.56 | US$970,878.24 | 17,703 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 1,843 | US$167.31 | US$308,352.33 | 15,860 | SEC |
| 2026-06-04 2026-06-08 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V Director | 卖出（S） | 1,250 | US$168.06 | US$210,075.00 | 2,838 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 3,520 | US$158.59 | US$558,236.80 | 22,374 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 9,521 | US$157.62 | US$150.07万 | 25,894 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 4,216 | US$156.77 | US$660,942.32 | 35,415 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 5,466 | US$155.46 | US$849,744.36 | 39,631 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 14,214 | US$154.83 | US$220.08万 | 45,097 | SEC |
| 2026-06-01 2026-06-02 | NBIX NEUROCRINE BIOSCIENCES INC | Onyia Jude Officer · Chief Scientific Officer | 卖出（S） | 11,000 | US$160.25 | US$176.28万 | 25,846 | SEC |
| 2026-05-29 2026-06-02 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 2,261 | US$156.71 | US$354,321.31 | 16,225 | SEC |
| 2026-05-27 2026-05-29 | NBIX NEUROCRINE BIOSCIENCES INC | Onyia Jude Officer · Chief Scientific Officer | 卖出（S） | 11,000 | US$155.53 | US$171.08万 | 25,846 | SEC |
| 2026-05-26 2026-05-28 | NBIX NEUROCRINE BIOSCIENCES INC | Boyer David W. Officer · Chief Corp. Affairs Officer | 卖出（S） | 3,888 | US$156.64 | US$609,016.32 | 7,799 | SEC |
| 2026-05-19 2026-05-21 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES Director | 卖出（S） | 245,088 | US$154.33 | US$3782.44万 | 511,293 | SEC |
| 2026-05-15 2026-05-18 | NBIX NEUROCRINE BIOSCIENCES INC | POPS RICHARD F Director | 卖出（S） | 15,000 | US$157.65 | US$236.48万 | 34,480 | SEC |
| 2026-05-14 2026-05-18 | LNBIX Lincoln Bain Capital Total Credit Fund | Lincoln Financial Investments Corp TenPercentOwner,Other | 买入（P） | 2,448,579.82 | US$10.21 | US$2500万 | 19,954,569.64 | SEC |
| 2026-05-12 2026-05-14 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V Director | 卖出（S） | 3,810 | US$155.01 | US$590,588.10 | 2,429 | SEC |
| 2026-04-16 2026-04-20 | LNBIX Lincoln Bain Capital Total Credit Fund | Lincoln Financial Investments Corp TenPercentOwner,Other | 买入（P） | 2,472,799.21 | US$10.11 | US$2500万 | 17,390,174.33 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| NBIX | 1,764,410.3825 | 15,875.5605 | 2,108,595.2203 | 83.68% | B, Q, N |